Ross B Fulton Selected Research

Triple Negative Breast Neoplasms

1/2020

Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross B Fulton Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2019
2	Inflammation (Inflammations) 08/2010 - 08/2008
1	Experimental Melanoma 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Infections 12/2013
1	Pneumonia (Pneumonitis) 09/2011
1	Lung Diseases (Lung Disease) 09/2011
1	Respiratory Syncytial Virus Infections 09/2011
1	Hepatitis 07/2010
1	Virus Diseases (Viral Diseases) 08/2008

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
2	Prostaglandins GIBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 10/2019
2	CytokinesIBA 12/2013 - 08/2008
1	Interferon Type IIBA 01/2022
1	LigandsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022
1	taxaneIBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2019
1	EpitopesIBA 12/2013
1	Interleukin-10 (Interleukin 10)IBA 09/2011
1	AllergensIBA 08/2010
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2010
1	Peptides (Polypeptides)IBA 08/2008

Therapy/Procedure

3	Immunotherapy 01/2022 - 10/2019
1	Drug Tapering 01/2020
1	Drug Therapy (Chemotherapy) 01/2020